Renaissance Technologies’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-203,800
| Closed | -$33.7M | – | 4048 |
|
|
2021
Q2 | $33.7M | Buy |
+203,800
| New | +$34M | 0.04% | 493 |
|
|
2020
Q4 | – | Sell |
-57,800
| Closed | -$5.86M | – | 3847 |
|
|
2020
Q3 | $5.86M | Buy |
57,800
+43,700
| +310% | +$4.46M | 0.01% | 1490 |
|
|
2020
Q2 | $1.37M | Buy |
+14,100
| New | +$1.31M | ﹤0.01% | 2390 |
|
|
2018
Q3 | – | Sell |
-105,400
| Closed | -$9.84M | – | 3648 |
|
|
2018
Q2 | $9.84M | Buy |
105,400
+5,800
| +6% | +$499K | 0.01% | 1363 |
|
|
2018
Q1 | $8.26M | Buy |
99,600
+86,900
| +684% | +$7.72M | 0.01% | 1487 |
|
|
2017
Q4 | $1.16M | Sell |
12,700
-123,800
| -91% | -$10.3M | ﹤0.01% | 2602 |
|
|
2017
Q3 | $10.4M | Buy |
136,500
+21,200
| +18% | +$1.6M | 0.01% | 1306 |
|
|
2017
Q2 | $8.65M | Sell |
115,300
-196,500
| -63% | -$13.6M | 0.01% | 1364 |
|
|
2017
Q1 | $20.3M | Buy |
+311,800
| New | +$18.4M | 0.03% | 795 |
|
|
2016
Q4 | – | Sell |
-4,400
| Closed | -$249K | – | 3560 |
|
|
2016
Q3 | $249K | Buy |
+4,400
| New | +$216K | ﹤0.01% | 3015 |
|
|
2016
Q1 | – | Sell |
-12,200
| Closed | -$552K | – | 3598 |
|
|
2015
Q4 | $552K | Sell |
12,200
-37,700
| -76% | -$1.58M | ﹤0.01% | 2705 |
|
|
2015
Q3 | $1.94M | Buy |
+49,900
| New | +$2M | ﹤0.01% | 2011 |
|
Other funds holding PRAH
Renaissance Technologies's PRAH Position: Q3 2021 in Review
Renaissance Technologies sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 203,800 shares — an estimated $33.7M sold.
Renaissance Technologies first reported a position in PRAH in Q3 2015 and held it in 12 quarters. The position peaked at $33.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Renaissance Technologies reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Renaissance Technologies sold 203,800 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $33.7M.
- Renaissance Technologies first reported a position in PRA Health Sciences, Inc. in Q3 2015 and held it in 12 quarters.
- Renaissance Technologies's PRA Health Sciences, Inc. position peaked at $33.7M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.